Mesoblast Ltd.Mesoblast Ltd.Mesoblast Ltd.

Mesoblast Ltd.

No trades
See on Supercharts
Market capitalization
‪584.99 M‬USD
‪−81.08 M‬USD
‪7.43 M‬USD
‪891.21 M‬
Beta (1Y)
0.95

About Mesoblast Ltd.

CEO
Silviu Itescu
Headquarters
Melbourne
Employees (FY)
83
Founded
2004
ISIN
AU000000MSB8
FIGI
BBG000RCF756
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MEOBF is 0.6051 USD — it has increased by 0.85% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Mesoblast Ltd. stocks are traded under the ticker MEOBF.
Mesoblast Ltd. is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
MEOBF stock is 10.02% volatile and has beta coefficient of 0.95. Check out the list of the most volatile stocks — is Mesoblast Ltd. there?
MEOBF earnings for the last quarter are −0.03 USD per share, whereas the estimation was −0.03 USD resulting in a 4.11% surprise. The estimated earnings for the next quarter are −0.04 USD per share. See more details about Mesoblast Ltd. earnings.
Mesoblast Ltd. revenue for the last quarter amounts to ‪1.90 M‬ USD despite the estimated figure of ‪2.38 M‬ USD. In the next quarter revenue is expected to reach ‪3.87 M‬ USD.
Yes, you can track Mesoblast Ltd. financials in yearly and quarterly reports right on TradingView.
MEOBF stock has risen by 0.85% compared to the previous week, the month change is a 218.31% rise, over the last year Mesoblast Ltd. has showed a 14.45% decrease.
MEOBF net income for the last quarter is ‪−33.95 M‬ USD, while the quarter before that showed ‪−52.69 M‬ USD of net income which accounts for 35.56% change. Track more Mesoblast Ltd. financial stats to get the full picture.
Today Mesoblast Ltd. has the market capitalization of ‪585.05 M‬, it has decreased by 3.36% over the last week.
No, MEOBF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MEOBF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Mesoblast Ltd. stock right from TradingView charts — choose your broker and connect to your account.
MEOBF reached its all-time high on Oct 24, 2011 with the price of 10.6400 USD, and its all-time low was 0.0100 USD and was reached on Oct 1, 2020.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has 83.00 employees. See our rating of the largest employees — is Mesoblast Ltd. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Mesoblast Ltd. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Mesoblast Ltd. stock shows the neutral signal. See more of Mesoblast Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Mesoblast Ltd. future price: according to them, MEOBF price has a max estimate of 1.70 USD and a min estimate of 0.40 USD. Read a more detailed Mesoblast Ltd. forecast: see what analysts think of Mesoblast Ltd. and suggest that you do with its stocks.